FEATURED: Visionaries - Stelios Papadopoulos - Part 1

You are Watching:

Visionaries: Stelios on Financing, Productivity, and the Cost of Innovation.

Stelios Papadopoulos, veteran of the Biotech Industry, looks at the financing environment today, and the "windowless paradigm" we've been operating in since 2003. He emphasizes the importance of changing investor sophistication and investment horizons. Stelios also addresses the cost of innovation and overall sector productivity. Finally Stelios looks back on his expectations for the market today, when he prepared them as an analyst 20 years ago.

This interview was conducted at the NASDAQ Marketsite, on June 25th, 2008, in New York City.

Featuring: * Stelios Papadopoulos, Chairman of the Board/Director/Founder at Exelixis, Inc. * Jean-Loup Romet-Lemonne, President & CEO of BioBusiness.TV

DISCLAIMER:
BIOBUSINESS.TV IS AN INDEPENDENT MEDIA, AND A PLATFORM FOR THE EXCHANGE OF IDEAS AND OPINIONS. BIOBUSINESS.TV STRIVES TO ENHANCE THE QUALITY AND ACCESSIBILITY OF INDUSTRY DATA, AND TO DELIVER INFORMATION THAT INVESTORS AND EXECUTIVES CAN RELY UPON TO MAKE SOUND, INFORMED FINANCIAL AND MANAGERIAL DECISIONS. VIEWERS SHOULD VERIFY ALL CLAIMS AND DO THEIR OWN DUE DILIGENCE BEFORE INVESTING IN ANY SECURITIES MENTIONED. INVESTING IN SECURITIES IS SPECULATIVE AND CARRIES A HIGH DEGREE OF RISK.

Category:

Science & Technology

Tags:

• Stelios
• Papadopoulos

[LitUpDASH]

@markmorgenbesser I did draft this guy on NBA 2k11 he retired at age 22 as a 54 overall i guess to become a financial mastermind.

[markmorgenbesser]

i would draft him on nba 2k11!